CNA Financial CEO Douglas Worman sells 40,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CNA Financial Corp. Chairman and CEO Douglas Worman sold 40,000 common shares on November 10, 2026, at a weighted average price of $48.07 per share. After the sale, Worman directly held 199,749 shares. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Net Seller: 40,000 shares
Net Sell
1 txn
Insider
Worman Douglas
Role
Chairman and CEO
Sold
40,000 shs ($1.92M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 40,000 | $48.07 | $1.92M |
Holdings After Transaction:
Common Stock — 199,749 shares (Direct)
Footnotes (1)
- F1. This transaction was executed in multiple trades at prices ranging from $47.95 to $48.185. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was affected.
Key Figures
Shares sold: 40,000 shares
Weighted average sale price: $48.07 per share
Trade price range: $47.95 to $48.185 per share
+1 more
4 metrics
Shares sold
40,000 shares
Douglas Worman's sale on November 10, 2026
Weighted average sale price
$48.07 per share
Sale on November 10, 2026
Trade price range
$47.95 to $48.185 per share
Prices across multiple trades
Direct shares held after sale
199,749 shares
Douglas Worman's reported position following the transaction
Key Terms
weighted average sale price, Rule 10b5-1 plan
2 terms
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
Rule 10b5-1 plan regulatory
"No Rule 10b5-1 plan is reported for the sale."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.